![]() | ![]() |
Formats:
|
||||||||
Copyright © Copyright 2005 by RNA Society Editing efficiency of a Drosophila gene correlates with a distant splice site selection Department of Genetics, Washington University Medical School, St. Louis, Missouri 63110-8232, USA Reprint requests to: Gary D. Stormo, Department of Genetics, Washington University Medical School, 660 S. Euclid, Box 8232, St. Louis, MO 63110-8232, USA; e-mail: stormo/at/genetics.wustl.edu; fax: (314) 362-7855. Received December 23, 2004; Accepted February 1, 2005. This article has been cited by other articles in PMC.Abstract RNA editing and alternative splicing are two processes that increase protein diversity. The relationship between the two processes is not well understood. There are a few examples of correlations between editing and alternative splicing, but these are all nearby effects. A search for alternative splicing among 16 edited genes in Drosophila reveals two novel instances of alternative splicing. In one example where alternative splicing occurs downstream of editing, a strong correlation between editing efficiency and splice site selection is observed. In contrast, when editing occurs downstream of alternative splicing, no correlation is seen. These results suggest some models for the coupling of editing and splicing processes. Keywords: editing, alternative splicing, ADAR INTRODUCTION Editing of exonic codons by adenosine deaminases that act on RNA (ADARs) and alternative splicing are two processes that increase protein diversity. The relative importance of both ADAR editing and alternative splicing increases with organismal complexity. In invertebrates, ADAR knockouts are viable with behavioral defects (Palladino et al. 2000; Tonkin et al. 2002). In mammals, however, ADAR editing of exons appears to be essential for viability (Brusa et al. 1995; Higuchi et al. 2000). Likewise, the extent to which an organism relies on alternative splicing for its protein repertoire increases from worms to humans (Kim et al. 2004b). In agreement with this association, there is a positive correlation between inosine content (Paul and Bass 1998) and the amount of alternative splicing (Yeo et al. 2004) where both editing and alternative splicing are most to least abundant in the brain, lung, and muscle, respectively. Given this concordance, and the reliance of exonic editing on intron-encoded exonic complementary sequences (ECS) (Higuchi et al. 1993), one might expect that the efficiency of the two processes would, in some cases, be coupled in vivo. The recent discovery of widespread editing of transcribed Alu elements, and their association with alternative splicing, is consistent with that expectation (Sorek et al. 2002; Athanasiadis et al. 2004; Kim et al. 2004a). There are a few examples of an association between alternative splicing and editing at (Rueter et al. 1999) or near (Maas et al. 2001; Flomen et al. 2004) splice sites and some suggestions that this may be a common phenomenon (Reenan et al. 2000; Bass 2002). The ADAR2 protein regulates its own synthesis by creating an alternative splice site that leads to an out-of-frame product (Rueter et al. 1999). Previous experiments have also shown changes in splice site selection of the exonically edited 5-HT2C receptor in response to changes in ADAR2 activity (Maas et al. 2001) or in vitro A-to-G substitutions at the editing sites (Flomen et al. 2004). In this case alternative splicing removes the edited region of the receptor mRNA, thereby preventing detection of an association between editing efficiency and alternative splicing in vivo. Editing of the glutmate receptor subunit B pre-mRNA was found to inhibit splicing in vitro, but in vivo both processes can occur without interference (Bratt and Ohman 2003). This indicates a mechanism in vivo for coordinating the two processes and the discrepancy between the in vitro and in vivo results underscores the importance of obtaining in vivo data about the correlation of the two events. In each of the previous examples the editing site and the affected splice site are in close proximity to one another. To determine if there might be correlations in the two processes that occur over long distances we studied two Drosophila genes that are both edited (Hoopengardner et al. 2003) and show alternative splicing. In one case the alternative splice sites are located far upstream (5′) of the editing site, and in the other case the alternative splices sites are located far downstream (3′) of the editing site. We find no difference in editing efficiency for the two upstream alternative products, but the two downstream products show dramatic differences in their editing efficiencies. RESULTS AND DISCUSSION To search for alternatively spliced products, we performed RT-PCR on each of the 16 recently discovered Drosophila edited genes (Hoopengardner et al. 2003) using primers for exons on either side of edited exons. For two of the genes, we discovered unreported alternative splice products that could not be attributed to intron retention events (Fig. 1A ![]() ![]() ![]()
Using spliceform-specific primers we then amplified each spliceform separately and cloned and sequenced a large number of each product to determine the fraction of each that were edited (Fig. 1B,C ![]() ![]() ![]() ![]()
These results show a correlation between editing efficiency and the choice of alternative splice sites. We propose two general models to explain the results.
The two models could be distinguished by analyzing the splicing pattern in the absence of RNA editing. Model 2 predicts that the 1.5/1 ratio of short to long products does not depend on editing. Model 1 predicts that the shorter product would be more highly prevalent, to a ratio of ~2/1, if the editing site were changed to match the edited sequence, i.e., if it were pre-edited. On the other hand, if editing were prevented, for instance, by modifying the ECS or in an ADAR mutant, then we would expect the longer form to predominate by a ratio of ~1.5/1. The two models are not mutually exclusive, and it is possible some combination of each leads to the observed result. It is also possible that some more complicated process is involved. In previous studies that have demonstrated an association between splicing and editing, the two sites were very close together (Rueter et al. 1999; Maas et al. 2001; Bratt and Ohman 2003; Flomen et al. 2004). Those examples could be explained by the editing sites altering the splice signals themselves or mRNA secondary structures that interfere with splicing. RNA editing is known to be important in many metazoan organisms. Invertebrates that lack editing activity show behavioral phenotypes (Palladino et al. 2000; Tonkin et al. 2002), whereas in mammals ADAR editing is essential for viability (Brusa et al. 1995; Higuchi et al. 2000). There is strong evidence that there are many editing sites yet to be discovered (Paul and Bass 1998) but experimental detection remains a difficult problem. Editing can alter a protein sequence and thereby affect its function (Bass 2002). It can affect the splicing of pre-mRNA, as shown in this report and in previous work. It can also alter gene expression, such as in the autoregulation of ADAR2 (Rueter et al. 1999) and by affecting mRNA degradation (Tonkin and Bass 2003). It is clear that a comprehensive analysis of gene functions and of gene expression patterns must take into account editing events and their correlations with other cellular processes. MATERIALS AND METHODS RNA isolation and reverse-transcriptase (RT)-PCR Total RNA was extracted from Canton-S fly heads with Trizol Reagent (Invitrogen) and treated with DNAse (DNA-Free, Ambion). Total RNA was used to synthesize cDNA using Superscript II reverse transcriptase (Invitrogen) and random hexamer primers. Amplification of CG15899 used primers 5′-CGCTCGTCACAGT GTTCCAG-3′ and 5′-GCGCTCGCGACGTTCATTTC-3′. Gene CG32975 was amplified using primers 5′-CACTCTGCCGCCA GATTCG-3′ and 5′-GCACTCGTCATCTTTACGTAGC-3′. CG15899 splice product identification Amplified products from CG15899 were T/A cloned into pGEM-TEasy Vector (Promega) and clones were screened for appropriately sized bands upon PCR amplification with M13F (−41) and M13R (−48) primers. Appropriately sized PCR products were cleaned by Exonuclease I/Shrimp Alkaline Phosphatase Treatment (USB) and sequenced by dideoxy sequencing. CG32975 splice product identification Amplified products from CG32975 represented a previously identified product (669 bp) and a smaller product that was larger than the CG32975RA spliceform. This product was characterized using a single primer specific to the expected CG32975RA spliceform coupled to one of the original primers used for amplification. The 3′ spliceform-specific primer produced a PCR product of the appropriate size, suggesting the product represented retention of CG32975RB exon 7 and deletion of exons 9, 10, and 11. Amplification of specific spliceforms Each splice product was amplified separately from bulk cDNA using a single spliceform-specific primer and a shared primer. For CG15899 the spliceform-specific primers were 5′-CAGCAT ACTCGGCATGTATCTG-3′ for spliceform 362 and 5′-CACAGTG TTCCAGATACTGACGCAAG-3′ for spliceform 197. These were coupled to the three prime primer 5′-GCGCTCGCGACGTTCAT TTC-3′. For CG32975 the spliceform-specific primers were 5′-CGTCATCTTTACGTAGCCATTCGGACATTTCG-3′ for spliceform 255 and 5′-CTTTACGTAGCTGATCAGTTATAAAG-3′ for spliceform 669. These were coupled to a shared forward primer 5′-TGCCTCCATGGCCTTGCTCGG-3′. All products were then Exo/Sap treated and sequenced. Quantification of RNA editing Splice products were amplified and cloned into the BamHI/HindIII site of the pUC19 Vector. Primers used for amplification of CG32975 splice products were forward: 5′-GCCGGATCCGGTA CATATTTCAATTGCATAATGTTTATGG-3′ and reverse: 5′-GC GAAGCTTCCATTCGGACATTTCGTGCG-3′. Primers used for amplification of CG15899 were forward: 5′-GGCGGATCCATAC TGACGCAAGAGGATTGG-3′ (form 362), 5′-GGCGGATCC GATACTGACGCAAGAGGATTGG-3′ (form 197) and reverse 5′-GTCAAGCTTGCTCGCGACGTTCATTTCGC-3′. Relative A-to-G abundance was determined by sequencing individual clones with plasmids containing appropriately sized inserts. Quantification of spliceform abundance Populations of mixed spliceforms obtained from RT-PCR of Drosophila cDNA were subjected to gel electrophoresis and stained with ethidium bromide. The stained gel was scanned on a Typhoon Scanner (Amersham) and the relative abundance of each band was measured with the image analysis program Imagequant (Amersham). Values were normalized against background readings. Final values were obtained as the average of three readings. Relative molar abundances were obtained by correcting for differences in product size. Acknowledgments We thank Barak Cohen, Rob Mitra, and the members of their laboratories for many helpful comments. We thank Larry Schriefer and Yiing Lin for technical assistance. G.D.S. was supported by NIH grant HG00249 and R.A. was supported by NIH training grant GM08802. Notes Article and publication are at http://www.rnajournal.org/cgi/doi/10.1261/rna.7280605. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||
Cell. 2000 Aug 18; 102(4):437-49.
[Cell. 2000]EMBO J. 2002 Nov 15; 21(22):6025-35.
[EMBO J. 2002]Science. 1995 Dec 8; 270(5242):1677-80.
[Science. 1995]Nature. 2000 Jul 6; 406(6791):78-81.
[Nature. 2000]Nat Genet. 2004 Sep; 36(9):915-6; author reply 916-7.
[Nat Genet. 2004]Nature. 1999 May 6; 399(6731):75-80.
[Nature. 1999]Proc Natl Acad Sci U S A. 2001 Dec 4; 98(25):14687-92.
[Proc Natl Acad Sci U S A. 2001]Nucleic Acids Res. 2004; 32(7):2113-22.
[Nucleic Acids Res. 2004]Neuron. 2000 Jan; 25(1):139-49.
[Neuron. 2000]Annu Rev Biochem. 2002; 71():817-46.
[Annu Rev Biochem. 2002]Science. 2003 Aug 8; 301(5634):832-6.
[Science. 2003]Science. 2003 Aug 8; 301(5634):832-6.
[Science. 2003]Nucleic Acids Res. 2003 Jan 1; 31(1):172-5.
[Nucleic Acids Res. 2003]Genetics. 2002 Apr; 160(4):1519-33.
[Genetics. 2002]Hum Mol Genet. 2002 Feb 15; 11(4):451-64.
[Hum Mol Genet. 2002]Neuron. 2000 Jan; 25(1):139-49.
[Neuron. 2000]Hum Mol Genet. 2002 Feb 15; 11(4):451-64.
[Hum Mol Genet. 2002]Neuron. 2000 Jan; 25(1):139-49.
[Neuron. 2000]Nature. 1999 May 6; 399(6731):75-80.
[Nature. 1999]Proc Natl Acad Sci U S A. 2001 Dec 4; 98(25):14687-92.
[Proc Natl Acad Sci U S A. 2001]RNA. 2003 Mar; 9(3):309-18.
[RNA. 2003]Nucleic Acids Res. 2004; 32(7):2113-22.
[Nucleic Acids Res. 2004]Cell. 2000 Aug 18; 102(4):437-49.
[Cell. 2000]EMBO J. 2002 Nov 15; 21(22):6025-35.
[EMBO J. 2002]Science. 1995 Dec 8; 270(5242):1677-80.
[Science. 1995]Nature. 2000 Jul 6; 406(6791):78-81.
[Nature. 2000]EMBO J. 1998 Feb 16; 17(4):1120-7.
[EMBO J. 1998]